Scholarlink

Background and objectives <p>Iron metabolism abnormalities are prevalent among end-stage renal disease (ESRD) patients. However, evidence regarding the association between iron status and cardiovascular outcomes, particularly in peritoneal dialysis (PD) patients, remains limited and inconsistent. This retrospective cohort study aimed to investigate the relationship between serum ferritin levels and the risk of cardiovascular composite endpoint events in PD patients.</p> Methods <p>We conducted a single-center retrospective cohort study involving adult patients undergoing continuous ambulatory peritoneal dialysis (CAPD) for ≥ 3&#xa0;months between January 1, 2017 and December 31, 2024. Serum ferritin levels were measured at 3&#xa0;months (± 1&#xa0;month) after CAPD initiation to reflect stable iron status. Participants were stratified into four groups based on baseline serum ferritin quartiles. Multivariable Cox proportional hazards regression models and restricted cubic spline (RCS) analyses were used to evaluate the association between serum ferritin levels and cardiovascular composite endpoints.</p> Results <p>A total of 418 patients were enrolled, with a median follow-up of 33&#xa0;months (IQR: 16–54). During this period, 48 (11.5%) composite endpoint events occurred, including 20cases (41.7%) of hospitalization for congestive heart failure and 28cases (58.3%) of cardiovascular death. Multivariable Cox regression analysis revealed that, in the fully adjusted model, the risk of composite endpoint events was significantly higher in the highest ferritin quartile (Q4) compared to the lowest quartile (Q1) (HR = 1.84, 95% CI 1.33–2.56, <i>P</i> &lt; 0.001). When analyzed as a continuous variable, serum ferritin was also associated with increased risk (HR = 1.97, 95% CI 1.40–2.76, <i>P</i> &lt; 0.001) Trend tests across all models were significant (<i>P</i> &lt; 0.001). Fully adjusted RCS regression models indicated a positive linear association between serum ferritin levels and the risk of cardiovascular composite endpoints (<i>P</i> for nonlinearity = 0.381). Subgroup analyses confirmed the consistency of this positive correlation across all predefined subgroups, with no significant interaction effects (all P for interaction &gt; 0.05).</p> Conclusions <p>Serum ferritin levels are positively and linearly associated with the risk of cardiovascular composite endpoints in PD patients, suggesting its potential value as a predictive biomarker for these events.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Association between serum ferritin levels and risk of cardiovascular composite endpoint events in peritoneal dialysis patients: a retrospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月17日

查看全文
  • Xiang-Qi Wu,
  • Guang-Yan Liu,
  • Qi Wang,
  • Run-Sen Liang,
  • Yong-Mei Cai,
  • Ji-Xin Tang,
  • Hua-Feng Liu,
  • Cui-Wei Yao

摘要

Background and objectives

Iron metabolism abnormalities are prevalent among end-stage renal disease (ESRD) patients. However, evidence regarding the association between iron status and cardiovascular outcomes, particularly in peritoneal dialysis (PD) patients, remains limited and inconsistent. This retrospective cohort study aimed to investigate the relationship between serum ferritin levels and the risk of cardiovascular composite endpoint events in PD patients.

Methods

We conducted a single-center retrospective cohort study involving adult patients undergoing continuous ambulatory peritoneal dialysis (CAPD) for ≥ 3 months between January 1, 2017 and December 31, 2024. Serum ferritin levels were measured at 3 months (± 1 month) after CAPD initiation to reflect stable iron status. Participants were stratified into four groups based on baseline serum ferritin quartiles. Multivariable Cox proportional hazards regression models and restricted cubic spline (RCS) analyses were used to evaluate the association between serum ferritin levels and cardiovascular composite endpoints.

Results

A total of 418 patients were enrolled, with a median follow-up of 33 months (IQR: 16–54). During this period, 48 (11.5%) composite endpoint events occurred, including 20cases (41.7%) of hospitalization for congestive heart failure and 28cases (58.3%) of cardiovascular death. Multivariable Cox regression analysis revealed that, in the fully adjusted model, the risk of composite endpoint events was significantly higher in the highest ferritin quartile (Q4) compared to the lowest quartile (Q1) (HR = 1.84, 95% CI 1.33–2.56, P < 0.001). When analyzed as a continuous variable, serum ferritin was also associated with increased risk (HR = 1.97, 95% CI 1.40–2.76, P < 0.001) Trend tests across all models were significant (P < 0.001). Fully adjusted RCS regression models indicated a positive linear association between serum ferritin levels and the risk of cardiovascular composite endpoints (P for nonlinearity = 0.381). Subgroup analyses confirmed the consistency of this positive correlation across all predefined subgroups, with no significant interaction effects (all P for interaction > 0.05).

Conclusions

Serum ferritin levels are positively and linearly associated with the risk of cardiovascular composite endpoints in PD patients, suggesting its potential value as a predictive biomarker for these events.